Orasure Quickflu Rapid Flu A & B Test, 22 Tests Box # 1001-0320

SENSITIVITY TO MEET YOUR NEEDS

OraSure QuickFlu® is an FDA cleared, CLIA-waived in vitro rapid qualitative test for the detection and differentiation of influenza type A and type B. An easy nasal swab procedure provides accurate results in as little as 10 minutes.

Orasure QuickFlu® delivers highly accurate results for flu types A and B and meets FDA’s new standards of performance.

• Proven analytical sensitivity across 51 different flu strains including CDC’s 2019-2020 flu strain panels
• Exceptional correlation to culture/PCR

PROVEN PERFORMANCE THAT MEETS FDA’S RECLASSIFICATION RULES

OraSure QuickFlu® exceeds the FDA’s reclassification requirement minimums for RIDTs.

• As of February 13, 2017, all RIDTs must meet the minimum acceptance performance criteria and comparator method for antigen based RIDTs. Tests that do not meet the new requirements cannot be used.
• Analytical reactivity testing must be performed on contemporary influenza strains and newly emerging strains in the event of an emergency.

ENSURES RESPONSIVE STANDARD OF CARE

• Simple, easy-to-use procedure with built-in control line
• Includes a flocked swab that optimizes sample collection and release resulting in superior performance
  • American Society of Microbiology says, “NP flocked swabs collect better samples than routine NP swabs”
• Nasal swab collection – comfortable for the patient and simple for the HCP with no ancillary supplies required
• Ready-to-use reagents with room temperature storage
• Rapid testing that maximizes results

TEST AT THE POINT OF CARE

OraSure QuickFlu® is ideal for testing at the point of care in…

• Laboratories
• Emergency Rooms
• Physician Offices
• Public Health Facilities and Clinics

REIMBURSEMENT INFORMATION

CPT Codes

87804 QW- Influenza A Detection

87804-59- Influenza B Detection